STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.
Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.